Severe Aplastic Anemia Study Recruits

NHLBI seeks adults with severe aplastic anemia (SAA) for a research study determining viability and safety of early initiation of oral therapy with cyclosporine and eltrombopag in patients with SAA. All patients will receive standard treatment with cyclosporine, eltrombopag and horse antithymocyte globulin (h-ATG) unless there is complete count recovery with oral therapy. Compensation will be provided. For more information, call the Office of Patient Recruitment at 1-866-444-2214 (TTY users dial 711). Refer to study 20-H-0033. Online: https://go.nih.gov/KnlRIpY.